Q3 2025 PAVmed Inc Earnings Call Transcript

Nov 13, 2025 / 01:30 PM GMT

Transcript 8-K10-Q

Key Points

Positve

PAVmed Inc (PAVM) has successfully restructured its debt, positioning the company for improved financial stability.
Lucid Diagnostics, a key subsidiary, is on the verge of securing Medicare coverage, which could significantly boost its commercialization efforts.
The company has raised substantial capital, extending Lucid's financial runway through 2026, indicating strong investor confidence.
PAVmed Inc (PAVM) has launched the commercial phase of its strategic partnership with Ohio State University, targeting 1,000 patients in the first year.
The company is actively expanding its portfolio with innovative technologies, including a promising endoscopic imaging technology in partnership with Duke University and the University of North Carolina.

Negative

PAVmed Inc (PAVM) is still in the process of finalizing its corporate restructuring, indicating ongoing financial and operational adjustments.
The company faces challenges in capital markets and structural issues, which have constrained its broader vision.
Lucid Diagnostics' revenue and test volumes have remained consistent but have not shown significant growth, indicating potential stagnation.
The development of the implantable physiologic monitor is ongoing, with FDA submission planned for 2026, suggesting a lengthy timeline before commercialization.
PAVmed Inc (PAVM) has a non-GAAP loss of $446,000, reflecting ongoing financial pressures despite recent capital raises.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PAVM.OQ - PAVmed Inc
Q3 2025 PAVmed Inc Earnings Call
Nov 13, 2025 / 01:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to the PadMed's 3rd quarter 2025 business day conference call. At this time, all lines are in listen-only mode, and following the presentation, we will conduct a question-and-answer session. If at any time during this call you require immediate assistance, please press 0 for the operator. This call is being recorded on Thursday, November 13, 2025.

I will now turn the call over to Mr. Matt Riley, Padmed senior director of investor relations. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and good morning, everyone.

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.